HHC
ANGO icon

Hutchin Hill Capital’s AngioDynamics ANGO Stock Holding History

Hutchin Hill Capital’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-32,200
Closed -$522K – 728
2017
Q2 		$522K Sell
32,200
-19,600
-38% -$310K 0.02% 667
2017
Q1 		$899K Buy
51,800
+10,900
+27% +$182K 0.02% 498
2016
Q4 		$690K Buy
40,900
+20,677
+102% +$345K 0.02% 533
2016
Q3 		$355K Buy
20,223
+3,923
+24% +$63.6K 0.01% 493
2016
Q2 		$234K Buy
+16,300
New +$204K 0.01% 468

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SAM
Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return

Hutchin Hill Capital's ANGO Position: Q3 2017 in Review

Hutchin Hill Capital sold out of AngioDynamics (ANGO) in Q3 2017, closing a stake of 32,200 shares — an estimated $522K sold.

Hutchin Hill Capital first reported a position in ANGO in Q2 2016 and held it in 5 quarters. The position peaked at $899K in Q1 2017. 168 funds tracked by Wall St. Rank hold ANGO as of Q3 2017.

  • Hutchin Hill Capital reported no remaining AngioDynamics position as of Q3 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 32,200 AngioDynamics shares in Q3 2017, an estimated $522K.
  • Hutchin Hill Capital first reported a position in AngioDynamics in Q2 2016 and held it in 5 quarters.
  • Hutchin Hill Capital's AngioDynamics position peaked at $899K in Q1 2017.
  • 168 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2017.

Based on Hutchin Hill Capital's 13F filing for Q3 2017, filed 14 Nov 2017.